🇺🇸 FDA
Patent

US 11890346

Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein

granted A61KA61K47/545A61K47/555

Quick answer

US patent 11890346 (Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein) held by Northwestern University expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K47/545, A61K47/555